Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali

[1]  M. Chopp,et al.  Neurorestorative treatment of stroke: Cell and pharmacological approaches , 2006, NeuroRX.

[2]  M. Mathru Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial , 2010 .

[3]  J. Pickard,et al.  Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article. , 2009, Journal of neurosurgery.

[4]  T. Taylor Caring for children with cerebral malaria: insights gleaned from 20 years on a research ward in Malawi. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[5]  C. Newton,et al.  Can erythropoietin be used to prevent brain damage in cerebral malaria? , 2009, Trends in parasitology.

[6]  M. Eisenhut,et al.  Artemisinin derivatives versus quinine in treating severe malaria in children: a systematic review , 2008, Malaria Journal.

[7]  Stéphane Picot,et al.  Artesunate-erythropoietin combination for murine cerebral malaria treatment. , 2008, Acta tropica.

[8]  S. Ranque,et al.  Life-Threatening Malaria in African Children: A Prospective Study in a Mesoendemic Urban Setting , 2008, The Pediatric infectious disease journal.

[9]  N. Day,et al.  The management of patients with severe malaria. , 2007, The American journal of tropical medicine and hygiene.

[10]  J. Tumwine,et al.  Mannitol as adjunct therapy for childhood cerebral malaria in Uganda: A randomized clinical trial , 2007, Malaria Journal.

[11]  B. Neville,et al.  Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children. , 2007, JAMA.

[12]  A. Cerami,et al.  Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. , 2006, Kidney international.

[13]  D. Kwiatkowski,et al.  Standardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[14]  J. Golenser,et al.  Conventional and experimental treatment of cerebral malaria. , 2006, International journal for parasitology.

[15]  A. Buguet,et al.  Recombinant human erythropoietin prevents the death of mice during cerebral malaria. , 2006, The Journal of infectious diseases.

[16]  G. Enwere A review of the quality of randomized clinical trials of adjunctive therapy for the treatment of cerebral malaria , 2005, Tropical medicine & international health : TM & IH.

[17]  Arjen Dondorp,et al.  Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial , 2005, The Lancet.

[18]  A. Cerami,et al.  Emerging biological roles for erythropoietin in the nervous system , 2005, Nature Reviews Neuroscience.

[19]  K. Maiese,et al.  Erythropoietin on a Tightrope: Balancing Neuronal and Vascular Protection between Intrinsic and Extrinsic Pathways , 2004, Neurosignals.

[20]  M. Herrmann,et al.  Erythropoietin: Novel Approaches to Neuroprotection in Human Brain Disease , 2004, Metabolic Brain Disease.

[21]  P. Ghezzi,et al.  Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Ghezzi,et al.  Erythropoietin as an antiapoptotic, tissue-protective cytokine , 2004, Cell Death and Differentiation.

[23]  M. Rosenzweig,et al.  The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events. , 2004, Journal of pain and symptom management.

[24]  M. Omata,et al.  Blood pressure response to erythropoietin injection in hemodialysis and predialysis patients. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

[25]  P. Ghezzi,et al.  Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal Apoptosis , 2003, The Journal of experimental medicine.

[26]  M. Buemi,et al.  The Pleiotropic Effects of Erythropoietin in the Central Nervous System , 2003, Journal of neuropathology and experimental neurology.

[27]  P. Lewczuk,et al.  Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial , 2002, Molecular medicine.

[28]  Stuart A. Lipton,et al.  Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades , 2001, Nature.

[29]  P. Lewczuk,et al.  Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Charles R. Newton,et al.  Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. , 1998, Pharmacology & therapeutics.

[31]  D. Parry,et al.  Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[32]  B. Rafferty,et al.  Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties. , 1998, British journal of haematology.

[33]  D. Kwiatkowski,et al.  The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. , 1996, The Journal of infectious diseases.

[34]  R. Snow,et al.  Indicators of life-threatening malaria in African children. , 1995, The New England journal of medicine.

[35]  R. Micciolo,et al.  Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. , 1995, The Journal of infectious diseases.

[36]  M. Fukuda,et al.  Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. , 1989, Blood.

[37]  D. Warrell,et al.  Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. , 1982, The New England journal of medicine.